Evidence map›Paper›PMID 42260026›Full record

ReviewJournal of cardiovascular translational research2026

Large Animal Models of Tricuspid Regurgitation: Relevance, Limitations, and Future Directions.

Talia Sukienik, Kosuke Nakamae, Chihiro Miyagi, Grisha Yelisetty, Syed Faizullah Hussaini, Tatsuya Watanabe, Junya Matsuda, Satoshi Yuhara, Daisuke Onohara

Abstract readReview
In one paragraph

Review in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Talia Sukienik *Center for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Kosuke Nakamae *Center for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Chihiro Miyagi *Center for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Grisha YelisettyCenter for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Syed Faizullah HussainiCenter for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Tatsuya WatanabeCenter for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Junya MatsudaCenter for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Satoshi YuharaCenter for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Daisuke OnoharaCenter for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. Daisuke.Onohara@nationwidechildrens.org.ORCID 0000-0002-2101-9865

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite growing interest in tricuspid regurgitation (TR), evidence remains insufficient to define the optimal timing of intervention and therapeutic strategies, highlighting the need for robust experimental models. Existing large animal models of TR use diverse approaches and can be grouped into two categories: direct valvular interventions targeting the tricuspid leaflets, annulus, or chordae, and indirect induction through mechanisms such as increased right ventricular loading, pulmonary hypertension, or pacing-induced tachycardia. Although direct valvular interventions can reproducibly induce TR and are well suited for modeling primary TR, clinically prevalent secondary TR is driven by annular dilation, leaflet tethering, and right-sided chamber remodeling rather than intrinsic valvular injury. This gap represents a major limitation in the field. In this review, we compare large animal models of TR and outline key considerations to guide model selection, with a focus on approaches that more faithfully reproduce the pathophysiology of TR for mechanistic and translational research.

Indexed as

Disease Models, AnimalTricuspid ValveTricuspid Valve InsufficiencyAnimalsHumansSpecies SpecificityTranslational Research, BiomedicalVentricular Function, RightFunctional tricuspid regurgitationLarge animal modelsPulmonary hypertensionRight heart failureTricuspid regurgitation

Identifiers

PMID42260026
PMCPMC13246952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.